Skip to main content
. 2019 Mar 29;36(5):925–933. doi: 10.1007/s10815-019-01420-1

Table 1.

Demography and treatment results

AC-FET NC-LPS P value
No. of cycles 2611 8425
Maternal age (year) 31 (28, 35) 31 (28, 35) 0.722
BMI (kg/m2) 21.6(19.9, 23.5) 21.2 (19.6, 23.1) < 0.001
Basal FSH (miu/ml) 6.11 (5.1, 7.4) 6.2 (5.3, 7.4) 0.005
Primary subfertility 1050 (40.2) 3500 (41.5) 0.228
Causes of infertility (%)
 Teratospermia 344 (13.2) 1113 (13.2) 0.960
 Oligoasthenozoospermia 225 (8.6) 793 (9.4) 0.220
 Oviduct factor 2345 (89.8) 7524 (89.3) 0.462
 Endometrial thickness (mm) on translate day 10.8 (9.9, 11.7) 11.4 (10.4, 12.5) < 0.001
Number of transferred embryos (%) 0.605
 1 428 (16.4) 1313 (15.6)
 2 1997 (76.5) 6514 (77.3)
 3 186 (7.1) 598 (7.1)
Blastomere or blastocyst transfer (%) 0.015
 Blastomere transfer 1605 (61.5) 5399 (64.1)
 Blastocyst transfer 1006 (38.6) 3026 (35.9)
The day of development of frozen embryos 0.115
 Day 3 1605 (61.5) 5396 (64.0)
 Day 4 1 (0.0) 3 (0.0)
 Day 5 783 (30.0) 2379 (28.2)
 Day 6 222 (8.5) 647 (7.7)
Good-quality rate of the embryo implanted 1446 (56.8) 4703 (55.4) 0.188
Clinical outcomes
 Clinical pregnancy rate 1326 (50.8) 4708 (55.9) < 0.001
 Miscarriage rate 253 (19.1) 748 (15.9) 0.006
 Ectopic pregnancy rate 44 (3.3) 75 (1.6) 0.006
 Live birth rate 1025 (39.3) 3872 (46.0) < 0.001
 Multiple rated 235 (22.9) 1063 (27.5) < 0.001

Continuous measurements are summarised as median (1st quartile–3rd quartile) if asymmetrically distributed. Nominal measurements are summarised as n (%) unless stated otherwise. AC-FET, artificial cycle; NC-LPS, natural cycles with luteal phase support; BMI, body mass index; FSH, follicle-stimulating hormone; ET, embryo transfer